589. Oral Tablet Vaccination Induces Heightened Cross-Reactive CD8 T Cell Responses to SARS-COV-2 in Humans

BACKGROUND: Covid-19 has accelerated global demand for easily distributed vaccines. Furthermore, as variant SARS-CoV-2 strains that circumvent antibody responses emerge, cross-protective vaccines provide substantial public health benefits. Vaxart is developing a shelf stable oral tablet vaccine that...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Susan, Martinez, Clarissa, Cortese, Mario, Martinez, Josefina, Garg, Shaily, Peinovich, Nadine, Dora, Emery, Tucker, Sean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644266/
http://dx.doi.org/10.1093/ofid/ofab466.787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644266/
http://dx.doi.org/10.1093/ofid/ofab466.787

Ejemplares similares